Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

被引：0
|
作者：
Michael Gurevich
Gadi Miron
Rina Zilkha Falb
David Magalashvili
Mark Dolev
Yael Stern
Anat Achiron
机构：
[1] Multiple Sclerosis Center,
[2] Sheba Medical Center,undefined
[3] Sackler School of Medicine,undefined
[4] Tel Aviv University,undefined
来源：
BMC Neurology | / 15卷
关键词：
Multiple sclerosis; Secondary progressive; Interferon beta; Gene-expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] T1 hypointense lesions in secondary progressive multiple sclerosis:: effect of interferon beta-1b treatment
    Barkhof, F
    van Waesberghe, JHTM
    Filippi, M
    Yousry, T
    Miller, DH
    Hahn, D
    Thompson, AJ
    Kappos, L
    Brex, P
    Pozzilli, C
    Polman, CH
    BRAIN, 2001, 124 : 1396 - 1402
  • [22] A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a
    Zivadinov, R
    Zorzon, M
    Tommasi, MA
    Nasuelli, D
    Bernardi, M
    Monti-Bragadin, L
    Cazzato, G
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 216 (01) : 113 - 118
  • [23] Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy
    Caggiula, M
    Batocchi, AP
    Frisullo, G
    Angelucci, F
    Patanella, AK
    Sancricca, C
    Nociti, V
    Tonali, PA
    Mirabella, M
    CLINICAL IMMUNOLOGY, 2006, 118 (01) : 77 - 82
  • [24] Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis: A Retrospective Study
    Tenembaum, Silvia N.
    Banwell, Brenda
    Pohl, Daniela
    Krupp, Lauren B.
    Boyko, Alexey
    Meinel, Michael
    Lehr, Lorenz
    Rocak, Sanda
    di Cantogno, Elisabetta Verdun
    Moraga, Margaretha Stam
    Ghezzi, Angelo
    JOURNAL OF CHILD NEUROLOGY, 2013, 28 (07) : 849 - 856
  • [25] Beta-interferon exposure and onset of secondary progressive multiple sclerosis
    Zhang, T.
    Shirani, A.
    Zhao, Y.
    Karim, M. E.
    Gustafson, P.
    Petkau, J.
    Evans, C.
    Kingwell, E.
    van der Kop, M.
    Zhu, F.
    Oger, J.
    Tremlett, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (06) : 990 - 1000
  • [26] Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
    Maniscalco, Giorgia Teresa
    Manzo, Valentino
    Ferrara, Anne Lise
    Perrella, Alessandro
    Di Battista, Mariaelena
    Salvatore, Simona
    Graziano, Daniela
    Viola, Assunta
    Amato, Gerardino
    Moreggia, Ornella
    Cesare, Daniele Di Giulio
    Barbato, Stefano
    Servillo, Giovanna
    Longo, Katia
    Di Giovanni, Mario
    Scarpati, Barbara
    Muggianu, Simona Maria
    Longo, Giuseppe
    Russo, Giuseppe
    Andreone, Vincenzo
    De Rosa, Veronica
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
  • [27] Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of Interferon beta-1b in patients with Secondary Progressive Multiple Sclerosis
    Rieckmann, P
    Kruse, N
    Nagelkerken, L
    Beckmann, K
    Miller, D
    Polman, C
    Dahlke, F
    Toyka, KV
    Hartung, HP
    Stürzebecher, S
    JOURNAL OF NEUROLOGY, 2005, 252 (05) : 526 - 533
  • [28] Combination therapy with interferon beta-1a and sesame oil in multiple sclerosis
    Faraji, Fardin
    Hashemi, Mahya
    Ghiasabadi, Atefeh
    Davoudian, Sadaf
    Talaie, Afsoon
    Ganji, Ali
    Mosayebi, Ghasem
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 45 : 275 - 279
  • [29] Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation
    Zettl, Uwe Klaus
    Rommer, Paulus Stefan
    Aktas, Orhan
    Wagner, Torsten
    Richter, Joachim
    Oschmann, Patrick
    Cepek, Lukas
    Elias-Hamp, Birte
    Gehring, Klaus
    Chan, Andrew
    Hecker, Michael
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (11) : 1343 - 1359
  • [30] Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis
    Serarslan, G.
    Okuyucu, Ee
    Melek, Im
    Hakverdi, S.
    Duman, T.
    MULTIPLE SCLEROSIS, 2008, 14 (02): : 259 - 261
12345